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Background: Multidrug efflux pumps are membrane translocases that have the ability to extrude a variety of
structurally unrelated compounds from the cell. AcrD, a resistance-nodulation-cell division (RND) transporter, was
shown to be involved in efflux of highly hydrophilic aminoglycosides and a limited number of amphiphilic compounds
in E. coli. Here, a homologue of AcrD in the plant pathogen and causal agent of fire blight disease Erwinia amylovora
was identified.
Results: The substrate specificity of AcrD was studied by overexpression of the corresponding gene from a high-copy
plasmid in E. amylovora Ea1189-3, which is hypersensitive to many drugs due to a deficiency of the major multidrug
pump AcrB. AcrD mediated resistance to several amphiphilic compounds including clotrimazole and luteolin, two
compounds hitherto not described as substrates of AcrD in enterobacteria. However, AcrD was not able to expel
aminoglycosides. An acrD mutant exhibited full virulence on apple rootstock and immature pear fruits. RT-PCR analysis
revealed an induction of acrD expression in infected apple tissue but not on pear fruits. Moreover, a direct binding of
BaeR, the response regulator of the two-component regulatory system BaeSR, to the acrD promoter was observed as
has already been shown in other enterobacteria.
Conclusions: AcrD from E. amylovora is involved in resistance to a limited number of amphiphilic compounds, but in
contrast to AcrD of E. coli, it is not involved in resistance to aminoglycosides. The expression of acrD was up-regulated
by addition of the substrates deoxycholate, naringenin, tetracycline and zinc. AcrD appears to be regulated by the
BaeSR two-component system, an envelope stress signal transduction pathway.
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Erwinia amylovora is the causative agent of fire blight, a
destructive, contagious disease of apple, pear, and other
rosaceous plants [1]. All aerial parts of the hosts can be
infected by the pathogen. E. amylovora enters its host
plants through natural openings (e.g., flower nectaries or
leaf stomata) and wounds [2]. Upon entry, the fire blight
pathogen moves through intercellular spaces towards
the xylem [3]. Typical symptoms include flower necrosis,
immature fruit rot, shoot curvature (shepherd’s crook),
bacterial ooze secretion, and cankers on woody tissues* Correspondence: h.weingart@jacobs-university.de
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article, unless otherwise stated.[1]. The most effective method to treat infected plants is
pruning to remove all infected tissue.
However, fire blight can infect entire orchards within a
single growing season leading to devastating economic
losses [4]. Presently, there are no effective therapeutics
available to cure fire blight and therefore prevention is
considered the best solution to manage this plant disease.
Current control efforts are rather rare and rely primarily
on antibiotic applications (e.g., streptomycin or oxytetra-
cycline) to protect flowers. However, the use of antibiotics
for the management of fire blight is highly controversial
due to the potential risk of promoting the emergence and
spread of antibiotic resistance [5].
Gram-negative bacteria often possess multidrug efflux
transporters within the cytoplasmic membrane, which
have been found to recognize and expel a broad rangeCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Among the multidrug efflux pumps, members of the
resistance-nodulation-cell division (RND) family appear to
be the most effective efflux systems in Gram-negative
bacteria. RND transporters form a tripartite complex,
consisting of an inner membrane pump that recognizes
and captures the substrates, a periplasmic membrane fusion
protein (MFP) and an outer membrane channel [8,9].
AcrAB is the major multidrug efflux pump in E. coli and
shows high conservation among Gram-negative bacteria
[8,10-12]. AcrD, a close homolog of AcrB, is an RND-type
efflux pump characterized as a transporter of aminoglyco-
sides, a highly hydrophilic class of molecules, and as a
transporter of several amphiphilic compounds [13,14].
Typically, the inner membrane pump and the periplasmic
MFP are co-transcribed in tandem on polycistronic mRNA
molecules [15]. Interestingly, this is not the case for acrD,
which appears as a single gene and seemingly functions in
concert with AcrA, a MFP co-transcribed with AcrB [14].
Both AcrAB and AcrD efflux systems are also present
in the plant pathogen E. amylovora. AcrAB has already
been characterized as an efflux system required for
virulence of E. amylovora in resistance towards apple
phytoalexins and for successful colonization of the host
plant [16]. AcrAB of E. amylovora showed a similar
substrate spectrum as AcrAB of E. coli [17]. In this study,
the substrate specificity of AcrD from E. amylovora was
characterized and its contribution to virulence in apple
and pear analyzed. As it was found that acrD is expressed
only at low levels under in vitro conditions, we were inter-
ested in investigating whether the expression of the AcrD
transporter in E. amylovora is induced in planta.
Multidrug transporters are often expressed under control
of local, as well as, global transcriptional regulators [18].
Current data show that expression of acrD in E. coli can be
induced by the two-component regulatory system BaeSR
[19]. Two-component systems (TCS) play an important
role in the regulation of physiological processes in response
to environmental or cellular parameters and enable bac-
terial cells to adapt to changing environmental conditions.
TCSs typically consist of a membrane-bound histidine
protein kinase (HPK) whose autokinase activity is dependent
upon sensing a specific environmental stimulus (e.g., nutri-
ents, temperature, pH, toxins or oxidative stress) [20]. The
second protein of a TCS is a response regulator, onto which
a phosphoryl group is transferred from the phosphorylated
HPK, and which functions as a phosphorylation-activated
switch that regulates output responses within the cell caus-
ing changes in the expression of target genes [21,22].
BaeSR is a TCS that responds cell envelope damages in
E. coli [23]. The small core regulon of BaeSR includes
the RND-type transporters AcrD and MdtABC and the
periplasmic chaperone Spy [24]. The presence of a hom-
ologous BaeSR system in E. amylovora, prompted us toanalyze the impact of the response regulator BaeR on the
expression levels of acrD.
Herein, we report that overexpression of the RND pump
AcrD in an acrB-deficient mutant leads to increased resist-
ance to two substrates, clotrimazole and luteolin, previously
not described as substrates of AcrD in other enterobacteria.
In order to determine the promoter activity in vitro, we
utilized a transcriptional fusion of the promoter regions of
acrAB and acrD, respectively, with the reporter gene egfp.
We demonstrate that the response regulator BaeR is able
to bind to the upstream region of acrD in E. amylovora
Ea1189 and to induce acrD expression. Furthermore, we
show that the inactivation of the RND pump AcrD did
not result in reduction of virulence of E. amylovora on
host plants.
Results
Identification of an acrD homologue in E. amylovora Ea1189
A search with the BLASTP program (NCBI) using the
amino acid sequence of AcrD from E. coli K-12 as the
query (accession number P24177) identified a homologous
sequence in the genome of E. amylovora CFBP1430
(GenBank:EAMY_2508, annotated as cmeB). The anno-
tated protein EAMY_2508 is 18 amino acids shorter at the
N-terminus than the AcrD protein of E. coli. Comparison
of the acrD gene sequences from E. coli and E. amylovora
suggests that the EAMY_2508 gene of E. amylovora
CFBP1430 has been annotated with a wrong start codon.
Sequence analysis revealed an alternative ATG start codon
54 bp upstream of the annotated EAMY_2508 gene. The
18 amino acids, encoded by the 54 additional nucleotides,
are 100% identical to the N-terminal region of AcrD from
E. coli.
We used the genome sequence of E. amylovora CFBP
1430 to design primers to PCR amplify the respective
region from the genomic DNA of our model strain E.
amylovora Ea1189 whose genome sequence is not yet
available. The nucleotide sequence of acrD and its up-
stream region from E. amylovora Ea1189 show 100%
identity to EAMY_2508 and its upstream region from E.
amylovora CFBP1430 based on our sequencing results.
AcrD is a member of the RND superfamily of transporters
belonging to the Hydrophobe/Amphiphile Efflux-1 (HAE1)
family (Transporter Classification Database TC #2.A.6.2.7).
A BLASTP search (NCBI) of the deduced AcrD sequence
from E. amylovora Ea1189 as query identified homologous
multidrug efflux transporters with high degree of sequence
identity (78 - 95%) in several members of the Enterobacteri-
aceae family (see Additional file 1 for a phylogenetic tree).
A sequence alignment between AcrD from E. amylovora
Ea1189 and AcrD from E. coli K-12 showed that the
proteins share 79% identity and 89% similarity with each
other (see Additional file 2). Substituted amino acids were
distributed throughout the sequence, but they were at
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chemical score of minimum 4) [25-28] and no insertion
or deletion was observed.
Analysis of the up- and downstream regions flanking
the acrD homologues from E. amylovora, E. coli and S.
enterica revealed several differences (see Additional file 3)
including the two-component system NarQP located
upstream of acrD in E. amylovora. This system is involved
in the regulation of anaerobic nitrate/nitrite respiration,
and consists of the sensor kinase NarQ and the response
regulator NarP. In E. coli and S. enterica, only the sensor
kinase NarQ is present upstream of acrD. The response
regulator NarP is situated at different positions in the
genomes of E. coli and S. enterica. Moreover, the sizes
of the NarQ homologues are also disparate. NarQ of E.
amylovora Ea1189 is a protein consisting of 328 amino
acids, whereas the NarQ homologues of E. coli and S.
enterica consist of 566 amino acids.
The downstream region of acrD of E. amylovora Ea1189
contains an insertion of about 1.5 kb encoding several
small hypothetical proteins.
Transmembrane organization of AcrB and AcrD in
E. amylovora
In a previous study, the transmembrane organization of
AcrB and AcrD from E. coli was analyzed in silico, with 12
transmembrane-spanning domains (TMD) and 2 large
periplasmic loops predicted in both proteins [14]. A
similar approach was accomplished with AcrB and AcrD
from E. amylovora Ea1189 using the online tool TOP-
CONS [29]. Topology analysis predicted the typical 12
TMDs and 2 periplasmic loops between TMD1 and 2 and
TMD 7 and 8 for the RND-type efflux pumps AcrB and
AcrD from E. amylovora Ea1189 (see Additional file 4).
Phenotypic characterization of the acrD mutant
To evaluate the role of AcrD in antibiotic resistance and to
identify substrates of this RND-type efflux pump, suscepti-
bility tests of the wild type and the acrD mutant to a var-
iety of antimicrobial agents were performed. Deletion of
acrD resulted in no significant changes in sensitivity to
tested aminoglycosides, dyes or detergents. However, the
acrD mutant was 2-fold more sensitive to nitrofurantoin,
erythromycin, silver nitrate and sodium tungstate in com-
parison to the wild type (Table 1). The differences in sensi-
tivity were minor but reproducible. Complementation of
the acrD mutant with plasmid pBlueKS.acrD, which carried
the acrD gene of Ea1189 under control of the Plac, restored
resistance to all tested antimicrobials (data not shown).
Expression of acrD in an acrB-deficient mutant of
E. amylovora
To investigate the substrate specificity of AcrD from
Ea1189, overexpression of the corresponding gene from ahigh-copy plasmid was achieved in E. amylovora mutant
Ea1189-3, which is hypersensitive to many drugs due to a
deficiency of the major multidrug efflux pump AcrB [16].
Three overexpression plasmids were generated: pBlueKS.
acrD, expressing acrD under control of the lac promoter
(Plac), pBlueSK.acrD-ext, expressing acrD under control of
its native promoter (PacrD) and pBlueKS.acrD-ext, express-
ing acrD under control of both promoters Plac and PacrD.
As a control, a promoterless acrD gene was cloned in the
opposite direction of Plac. These plasmids were mobilized
into the acrB-deficient mutant Ea1189-3 and the sensitivity
of the transformants to various substrates were determined
(Table 1). Ea1189-3(pBlueKS.acrD), expressing acrD under
control of Plac, exhibited elevated resistance to clotrimazole
(2-fold), fusidic acid (2-fold), novobiocin (4-fold), hygro-
mycin B (2-fold), cadmium acetate (2-fold), zinc sulfate
(2-fold), bile salt (2-fold), deoxycholate (4-fold), and SDS
(2-fold). The expression of acrD under control of its native
promoter in Ea1189-3 showed an increase in resistance
similar to that of Plac-controlled acrD expression (data not
shown). When acrD was under control of both promoters,
Plac and PacrD, it conferred elevated resistance. Compared
to the control, Ea1189-3(pBlueKS.acrD-ext) displayed
increased resistance to clotrimazole (4-fold), fusidic
acid (8-fold), novobiocin (16-fold), hygromycin B (2-fold),
cadmium acetate (2-fold), zinc sulfate (2-fold), bile salt
(8-fold), deoxycholate (8-fold), SDS (2-fold), luteolin (8-fold)
and ethidium bromide (2-fold) (Table 1).RND-type efflux pump expression during cellular growth
To monitor the expression levels of the RND-type ef-
flux pumps AcrAB and AcrD at different growth states,
total RNA was isolated at distinct optical densities and
expression levels analyzed by quantitative RT-PCR.
The expression values were normalized to the highest
expression of the acrA and acrD transcript, respect-
ively (Figure 1A). While the expression levels of acrA
changed during the cell cycle, indicating a growth
phase-dependent transcription with the highest ex-
pression in the early exponential phase, acrD showed
constant expression during growth. Additionally, the
constant expression of acrD was also connected to a
low expression level as determined by Ct values (data
not shown).
Furthermore, we studied the effect of temperature on
activation of the RND-type efflux pump AcrD using
qRT-PCR. Bacteria were cultured in LB broth at 18°C
and 28°C, respectively, where 28°C represents the optimal
growth temperature and 18°C represents the temperature
at which several genes involved in pathogenicity showed
induction in E. amylovora [30,31]. However, no temperature
dependence of the acrD expression was observed in vitro
(data not shown).
Table 1 Antimicrobial susceptibility profiles from an E. amylovora wild-type strain, acrD mutant, acrB mutant
complemented with AcrD-overexpression plasmids pBlueSK.acrD (acrD under control of Plac) and pBlueKS.acrD-ext
(acrD under control of Plac and its native promoter PacrD) and acrB mutant complemented with control plasmid
pBlueSK.acrD (acrD in opposite orientation to Plac)
Drug MIC (μg/ml)a
Ea1189 Ea1189.acrD Ea1189-3 (pBlueSK.acrD) Ea1189-3 (pBlueKS.acrD) Ea1189-3 (pBlueKS.acrD-ext)
Plac < < acrD Plac > > acrD Plac, PacrD > > acrD
Antimicrobials
Benzalkonium chloride 12.5 12.5 1.2 1.2 ND
Chloramphenicol 3.1 ND 1.2 1.2 1.2
Clotrimazole > 1000 > 1000 6.2 12.5 25
Fusaric acid 500 500 500 500 500
Fusidic acid 250 250 3.1 6.2 25
Genistein > 5000 > 5000 62.5 62.5 62.5
Josamycin 125 125 3.1 3.1 3.1
Luteolin > 5000 > 5000 15.63 15.6 125
Naladixic acid 2.5 2.5 1.2 1.2 1.2
Naringenin 5000 5000 312 312 312
Nitrofurantoin 25 12.5 12.5 12.5 12.5
Norfloxacin 0.63 0.63 0.03 0.03 0.03
Novobiocin 250 250 6.2 25 100
Phloretin 5000 5000 625 625 625
Rifampicin 12.5 12.5 12.5 12.5 12.5
Tetracycline 1.5 1.5 1.2 1.2 1.2
Aminoglycosides
Amikacin 2.5 2.5 2.5 2.5 2.5
Gentamicin 2.5 2.5 2.5 2.5 2.5
Hygromycin B 100 100 62.5 125 125
Streptomycin 2.5 2.5 2.5 2.5 2.5
Tobramycin 2.5 2.5 2.5 2.5 2.5
Macrolids
Azithromycin 0.31 0.31 0.63 0.63 0.63
Clarithromycin 0.31 0.31 0.31 0.31 0.31
Erythromycin 0.63 0.31 0.16 0.16 0.16
Roxithromycin 1.25 1.25 0.16 0.16 0.16
Heavy metals
Cadmium acetate 12.5 12.5 25 50 50
Cobalt (II) chloride 625 625 1250 1250 1250
Copper (II) sulfate 1250 1250 1250 1250 1250
Nickel (II) chloride 1250 1250 2500 2500 2500
Silver nitrate 12.5 6.2 6.2 6.2 6.2
Sodium tungstate 125000 62500 125000 125000 125000
Zinc sulfate 156 156 156 312 312
Dyes
Acriflavine 50 50 6.2 6.2 6.2
Crystal violet 3.1 3.1 2.5 2.5 2.5
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Table 1 Antimicrobial susceptibility profiles from an E. amylovora wild-type strain, acrD mutant, acrB mutant
complemented with AcrD-overexpression plasmids pBlueSK.acrD (acrD under control of Plac) and pBlueKS.acrD-ext
(acrD under control of Plac and its native promoter PacrD) and acrB mutant complemented with control plasmid
pBlueSK.acrD (acrD in opposite orientation to Plac) (Continued)
Ethidium bromide 250 250 3.1 3.1 6.2
Rhodamine 6G > 100 > 100 3.1 3.1 3.1
Detergents
Bile salt 5000 5000 625 1250 5000
Deoxycholate > 1000 > 1000 312 1250 2500
SDS > 1000 > 1000 62.5 125 125
aMIC values were determined by the 2-fold dilution assay in three or more independent experiments with similar results. Boldface numbers indicate a higher or
lower MIC. ND, not determined.
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In order to monitor promoter activities of the RND-type
efflux pumps AcrAB and AcrD in E. amylovora, tran-
scriptional fusions of the acrA upstream region (140 bp)
and acrD upstream region (210 bp), respectively, to the
enhanced green fluorescence protein-encoding gene (egfp)
were constructed. To determine whether bacterial growth
influenced the promoter activity, fluorescence measurements
at several optical densities were performed (Figure 1B).
Our data indicated that the promoter activities of both
acrAB and acrD were constant throughout the growth
phases in LB broth. Furthermore, the activity of the acrD
promoter was 4 to 5-fold lower than the activity of the
acrAB promoter throughout growth.
Effect of substrate exposure on acrD expression
The expression of genes encoding multidrug efflux systems
can be influenced by substrates, which interact with regu-
latory proteins and therefore increase gene transcriptionFigure 1 Promoter activities of acrA and acrD from Erwinia amylovora
OD600, optical density at 600 nm. (A) Relative mRNA transcript abundance
quantitative RT-PCR. The relative mRNA level was related to the highest ave
(B) Expression of acrA and acrD as determined by transcriptional fusions w
pBBR.acrA-Pro.egfp and pBBR.acrD-Pro.egfp, respectively. Experiments were[32]. Above results prompted us to investigate whether
antimicrobials affect the expression of the acrD gene in
E. amylovora. Therefore, we utilized a transcriptional
fusion between the promoter region of acrD and egfp
(pBBR.acrD-Pro.egfp). In order to determine the pro-
moter activity of acrD, we developed a screening assay in
a 96-well-plate format. Antimicrobial compounds were
added to the plasmid-harboring cells by the 2-fold dilution
method and EGFP fluorescence was determined after 24
hours. Only fluorescence values from substrate concen-
trations that did not inhibit bacterial growth were plotted
versus optical density on a scatter plot (see Additional
file 5). Outliers, showing higher fluorescence than the
remaining dataset, thus potential inducers of acrD ex-
pression, were identified as deoxycholate, naringenin,
tetracycline and zinc sulfate. In the next step, the effect
on the activity of the acrD promoter was evaluated in
batch cultures. We included novobiocin and fusidic
acid since they were identified as substrates of AcrD in. The activity was determined in the course of growth in LB broth,
of acrA and acrD during cellular growth of Ea1189 as determined by
rage value determined for a gene, which was defined as 100%.
ith the reporter gene egfp. E. amylovora wild type was transformed with
performed in triplicates with similar results.
Table 2 Virulence assay on apple rootstock MM 106
Strain Re-isolated bacterial cellsa
1 dpi 5 dpi
Ea1189 2.5 × 106 ± 1.1 × 106 4.7 × 108 ± 1.1 × 108
Ea1189.acrD 6.1 × 106 ± 4.7 × 106 3.5 × 108 ± 1.1 × 108
aBacteria were inoculated by prick technique in the shoot tips with an
inoculum of 5 × 106 CFU/shoot. Establishment of a population of Erwinia
amylovora Ea1189 and acrD mutant (CFU/shoot) was determined 1 and 5 days
post inoculation (dpi), respectively.
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it displayed a 2-fold induction of acrD in qRT-PCR
analysis (data not shown). After 24 hours incubation,
the fluorescence signal was measured and normalized
to an OD600 of 0.1 (Figure 2). The tested substrates were
able to induce the acrD promoter by approximately 2 to
3-fold. Among the tested substrates, deoxycholate and
zinc, showed significant differences in comparison to the
control (P < 0.05).
Contribution of AcrD to virulence of E. amylovora on
apple rootstocks
To study the impact of AcrD on virulence of E. amylovora
Ea1189, apple rootstocks MM 106 were infected and the
development of disease symptoms was monitored. After
one week of incubation all infected shoots showed typical
disease symptoms including the shepherd’s crook-like
bending of the shoot tip, tissue necrosis and ooze forma-
tion surrounding the infection site. Furthermore, bacterial
populations were counted 1 and 5 day(s) post inoculation,
respectively. However, no significant differences between
the populations of the wild type and the mutant were
observed (Table 2).Figure 2 Promoter activity of acrD from Erwinia amylovora
determined by transcriptional fusions with the reporter egfp.
Fluorescence was determined 24 h after incubation of the bacteria
with various transporter substrates. Substrates were added to a final
concentration of 1:10 of the determined MIC values; deoxycholate
(50 μg/ml), zinc sulfate (15.6 μg/ml), tetracycline (0.16 μg/ml),
naringenin (31.2 μg/ml), novobiocin (1.2 μg/ml), fusidic acid
(0.31 μg/ml) and tannin (500 μg/ml). The dotted line indicates the
basal acrD promoter activity. Statistically significant differences
(P < 0.05) are indicated by asterisks (*) and were determined by a
two-sided t-test with equal variances. a.u., arbitrary units.Additionally, immature pear fruits were infected with
the wild type and the acrD-deficient mutant and disease
symptoms were monitored by means of the diameter of
necrotic tissue surrounding the infection site (Figure 3).
After 8 days of incubation, when the pear fruit was almost
completely necrotic, no significant differences between
the wild type and the mutant were observed.Transcriptional analysis of acrA and acrD of E. amylovora
in planta
In order to analyze the acrA and acrD promoter activities
in planta, Ea1189 was infected into shoot tips of apple
rootstocks MM 106 as well as into immature pear fruits.
Several hours (pears) and days (apple shoots), respectively,
after inoculation bacteria were re-isolated by macerating
infected plant areas. Total RNA was isolated from recovered
cells and transcript abundances of acrA and acrD were
determined by quantitative RT-PCR. RT-PCR signals of
recovered bacteria were compared with RT-PCR signals
of Ea1189 cells grown in LB broth to an OD600 of 0.5.
For immature pear infections, we first determined the
expression of the sigma factor HrpL, which coordinatesFigure 3 Virulence of Erwinia amylovora Ea1189 wild type and
the acrD-deficient mutant on immature pear fruits. Symptoms
were monitored starting from the 3rd day post inoculation (dpi) until
the fruits were completely necrotic (around 8 dpi). Data values
represent the means of 6 replicates ± standard deviation.
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and pathogenicity (hrp) type III secretion system in E.
amylovora, to identify the time of maximal expression of
plant-inducible hrp genes. Compared to growth in LB broth,
hrpL expression was 9-fold higher 6 h post inoculation
into immature pears; after 12 h, expression was greatest
(40-fold induction), and after 18 h, hrpL expression de-
creased again (10-fold induction). Hence, we investigated
the expression of acrA and acrD genes with Ea1189 cells
recovered from infected immature pear fruits 12 h after
inoculation and compared them with cells grown in LB
broth to an OD600 of 0.5 (Table 3). Our results indicated
that neither acrA nor acrD are induced in the early infec-
tion phase of immature pear fruits.
For apple rootstock infections, bacteria were re-isolated
1, 4 and 7 days after inoculation, respectively, and com-
pared the abundance of acrA and acrD transcripts with
cells grown in LB broth (Table 3). Due to the high activity
of the acrA promoter in LB broth, expression analysis by
quantitative RT-PCR revealed a down regulation of this
gene in planta. On the other hand, since acrD was only
expressed at a low level during cellular growth in LB
broth, it showed a more than 3-fold induction in planta.
Regulation of the RND-type multidrug efflux pump AcrD
in E. amylovora
In other enterobacteria, e.g., E. coli and S. enterica, BaeR
is involved in the regulation of the RND-type efflux pumps
MdtABC and AcrD [19,34]. BaeR is the response regulator
of the two-component system BaeSR, which controls a
small set of adaptive factors involved in a unique envelope
stress response in E. coli [23]. A BLASTP search using the
amino acid sequence of BaeR from E. coli K12 as the
query identified a homologous sequence in the genome of
E. amylovora CFBP1430 (GenBank:EAMY_2266). These
homologues share 74% amino acid sequence identity with
each other.
In order to test whether BaeR plays a role in the regula-
tion of the acrD promoter in E. amylovora, we analyzedTable 3 Relative fold-changes in mRNA transcripts of acrA
and acrD after inoculation of Erwinia amylovora Ea1189
on apple rootstocks MM106 and immature pear fruit
slices, respectivelya
Gene Apple rootstock Immature pear
1 dpib 4 dpi 7 dpi 12 hpic
acrA −6.9 −5.8 −10.4 1.2
acrD 3.9 3.5 3.6 1.1
aTotal RNA was isolated from bacterial cells recovered from infected plant
tissues. Transcript abundance of acrA and acrD was determined by
quantitative RT-PCR and was compared to RT-PCR signal from cells grown in
LB broth to an OD600 of 0.5.
bBacteria were re-isolated from infected shoots of apple rootstock 1, 4 and 7
days post inoculation (dpi).
cBacteria were re-isolated from infected immature pears 12 hours post
inoculation (hpi).whether the published BaeR-binding site sequence motif
from E. coli (5′-TTTTTCTCCATDATTGGC-3′) is present
in the plant pathogen [35]. Indeed we identified a simi-
lar motif resembling the BaeR binding box located at
position −166 to −148 bp upstream of the coding se-
quence of acrD in Ea1189: 5′-TTCTTCACGATTACT
GGC-3′ (bold letters indicate mismatches to the consensus
sequence of E. coli).
To confirm the binding of BaeR to the acrD promoter
in vitro, an electrophoretic mobility shift assay (EMSA)
was performed. DNA fragments used in the EMSA were
the Cy5-labeled upstream region of acrD (246 bp), and
as controls, the upstream regions of acrAB (205 bp) and
tolC (291 bp). The DNA fragments were incubated with
increasing amounts of purified BaeR protein in presence of
nonspecific competitor DNA (Salmon sperm) (Figure 4).
The purified BaeR protein showed binding to the upstream
region of acrD with increasing concentrations, which was
detected as a smear (Figure 4A). A slight interaction
between the acrAB promoter and BaeR was detected at
the highest protein concentration (64 pM), which could
suggest an unspecific binding (Figure 4B). No interactions
between the fragment of the promoter region of tolC and
BaeR were detected (Figure 4C). These results show that
BaeR binds to the acrD regulatory region and is probably
involved in its regulation.
Induction of acrD through overexpression of BaeR
Owing to the interaction between the acrD promoter
region and BaeR observed during EMSA assays, we in-
vestigated whether overexpression of BaeR may induce
the expression of acrD. Therefore, we cloned baeR under
an arabinose-inducible promoter (pBAD24.baeR) and per-
formed qRT-PCR analysis 1 hour after induction. Relative
fold-changes in mRNA transcripts of acrA (0.8-fold), acrD
(3.8-fold) and tolC (0.7-fold) were determined. The obtained
data values correlate with the observed interaction of
BaeR during EMSA indicating a specific binding of BaeR
to the regulatory region of acrD.
Discussion
Bacteria have evolved energy-dependent multidrug efflux
pumps in order to prevent intracellular accumulation of
toxic compounds, including antimicrobials, antibiotics, dyes
and detergents [6,34]. In several enterobacteria, including
the human pathogen E. coli and the plant pathogen E.
amylovora, the RND transporter AcrAB-TolC has been
described as the major multidrug efflux system providing
resistance towards lipophilic and amphiphilic substrates
but not towards hydrophilic compounds [6,16]. Another
member of the RND family, AcrD, has been shown to
efficiently efflux highly hydrophilic aminoglycosides from
E. coli cells [13]. Here, we identified a gene encoding AcrD
in E. amylovora Ea1189, which shows significant sequence
Figure 4 Electrophoretic mobility shift analysis of BaeR interaction with Cy5-labeled DNA fragments. DNA fragments contain the
promoter regions of (A) acrD (246 bp), (B) acrA (205 bp) and (C) tolC (291 bp), respectively. Approximately 0.16 pmol of the DNA fragments were
incubated with increasing amounts of His-tag purified BaeR (indicated at the top of each lane). The DNA-protein complexes were separated on
4% non-denaturing polyacrylamide gels.
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E. coli and investigated the role of this transporter in the
fire blight pathogen.
Due to the high level of homology shared by AcrD
from E. coli and E. amylovora, it was not surprising to find
similar substrate specificities. Previous studies of AcrD in
E. coli have characterized it as an efflux transporter which
provides resistance to hydrophilic aminoglycosides as
well as to some amphiphilic compounds such as bile
acids, novobiocin and fusidic acid [14,33]. It has also been
reported that deletion of acrD does not cause hypersus-
ceptibility to amphiphilic drugs [36,37], which may be due
to low expression levels during cellular growth [14]. We
have been able to detect similar low expression levels of
acrD in E. amylovora Ea1189 during growth in LB broth
(Figure 1A). Moreover, we were unable to detect hypersus-
ceptibility to any of the tested antimicrobial compounds in
an acrD-deficient mutant (Table 1).
As noted for other bacteria, the overproduction of
AcrD in an acrB-deficient host led to increased resistance
towards detergents, novobiocin and fusidic acid [14,35].
Overproduction of AcrD in an acrB-deficient mutant of
E. amylovora Ea1189 increased the resistance to several
antimicrobial compounds and heavy metals. It is note-
worthy that expression of acrD under control of the lac
promoter displayed only a minor effect on the resistance
level compared to acrD expression driven by a combination
of the lac promoter and the native promoter (up to 16-fold
changes in MICs, Table 1). It has previously been reported
that strong overproduction of AcrD may interfere with
normal activity of the pump [14].In this study, we identified two new substrates, clotrima-
zole and luteolin, which increased the substrate spectrum
of AcrD in enterobacteria. Clotrimazole is a derivative
of imidazole, commonly used in the treatment of fungal
infections, and acts primarily by inhibiting the activity of
cytochrome P450 mono-oxygenase [38]. Luteolin is one of
the most common flavonoids present in many plant fam-
ilies. One of the functions of flavonoids in plants is their
protective role against microbial invasion. Luteolin was
shown to inhibit bacterial N-acetyltransferase activity [39].
Since AcrD conferred resistance to aminoglycosides in
E. coli [13], we hypothesized that AcrD of E. amylovora
would display a similar substrate spectrum. However,
overexpression of AcrD in E. amylovora Ea1189-3 did
not increase the MICs of the aminoglycosides amikacin,
gentamicin, streptomycin, and tobramycin. Although it is
important to note that we observed occasional, but not re-
producible, 2-fold differences between the aminoglycoside
MICs for different experiments (data not shown). While
this result is contradictory to previous findings for E. coli
[13], it may reflect a possible adaptation of the AcrD
transporter to a particular physiological function during
growth in the plant environment.
To elucidate the role of AcrD in the plant environment,
we analyzed whether this RND-type efflux pump is in-
volved in pathogenesis of the plant pathogen. Previously,
we have observed that disruption of the AcrB efflux pump
in E. amylovora significantly reduced virulence on apple
rootstock [16]. This prompted us to evaluate the effect
of AcrD on the virulence of the fire blight pathogen by
studying development of disease symptoms. However,
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acrD-deficient mutant conferred typical symptoms on
all inoculated shoots, indicating that the disruption of
the efflux pump had negligible impact on virulence on
apple rootstock. As the host range of E. amylovora also
includes pear trees, we further investigated the virulence
of the wild type and its acrD-deficient mutant on immature
pear fruits (cv. ‘Bartlet’) with the conclusion that AcrD is
not involved in the interaction of the fire blight pathogen
with this host.
Additionally, we studied the expression levels of the
AcrAB and AcrD efflux pumps in vitro and in planta,
respectively. The activity of the acrA promoter was lower
in planta than in LB medium (Table 3). However, it is pos-
sible that growth of the bacteria in LB broth may increase
expression of the AcrAB pump. A similar induction of the
RND-type efflux system MexAB-OprM in Pseudomonas
syringae was observed during growth in complex King’s B
medium [40]. Specific components of the complex media
might induce the expression of these RND efflux systems.
Alternatively, the efflux pumps may play a role in the
secretion of metabolites during exponential growth of
bacteria in complex medium.
The level of acrD expression was low during growth in
LB medium (Figure 1B), whereas it was slightly induced in
planta (Table 3) indicating that plant-derived compounds
are able to induce the AcrD pump. The nature of these
compounds remains to be elucidated.
Several multidrug transporters are induced in response
to the presence of toxic substances [18]. We identified
the substrates deoxycholate, naringenin, tetracycline, no-
vobiocin, fusidic acid, tannin and zinc as inducers of acrD
in E. amylovora. In prokaryotes, the expression of drug
transporter genes is frequently mediated by transcriptional
regulatory proteins, whose genes are often located adjacent
to those encoding the transport system. However, no local
transcriptional regulator was identified flanking the acrD
gene in E. amylovora, suggesting that expression of acrD
may be subject to regulation at the global level.
The acrD gene belongs to the regulon of the envelope
stress response, two-component system BaeSR in E. coli
and Salmonella enterica. A baeSR-deficient mutant of E.
amylovora Ea1189 has previously been evaluated for
virulence on immature pears, and exhibit full-virulence,
as that of wild type, on immature pear fruits [41]. The
core regulon of BaeSR consists of spy, encoding a protein
chaperon, and the RND efflux pump genes acrD and
mdtABC [42]. Interestingly, we identified a partial overlap
between the compounds inducing expression of acrD
in E. amylovora and baeR in E. coli, e.g., flavonoids
(naringenin), zinc, and tannin [24,42]. Accordingly, the
contribution of the two-component system BaeSR to
regulation of the acrD gene in E. amylovora became of
particular interest to us. In E. coli and S. enterica, BaeR,upon activation by phosphorylation through BaeS, binds to
the upstream promoter region of mdtA and acrD [19,35].
Our results showed that BaeR of E. amylovora is able to
bind the promoter region of acrD in E. amylovora, but
not to the promoter regions of acrA or tolC (Figure 4).
Additional investigation of the regulatory networks con-
trolling expression of acrD in growth cultures and in
natural environments, such as within host plants, will
need to be conducted in order to provide further in-
sights into the role of this multidrug transporter in the
physiology of the cell.
In summary, we have identified a homologue of the
RND-type multidrug efflux pump AcrD in E. amylovora
Ea1189. Despite the fact that AcrD of Ea1189 was unable
to efflux aminoglycosides, we detected a similar substrate
spectrum compared to homologues of AcrD from other
enterobacteria. Finally, we identified two substrates, clotri-
mazole and luteolin, hitherto unreported as substrates of
AcrD in E. coli and S. enterica.
Conclusions
The aim of the present study was the characterization of
AcrD, a RND-type multidrug efflux pump from the plant
pathogen E. amylovora, causing fire blight on apple and
pear. Our results demonstrated that AcrD plays a role in
drug resistance to a limited number of amphiphilic com-
pounds. We showed that the substrate specificity of AcrD
from E. amylovora and of AcrD from E. coli is partly over-
lapping. However, in contrast to AcrD from E. coli, AcrD
from E. amylovora cannot provide resistance towards ami-
noglycosides. The expression of acrD was up-regulated by
the addition of several substrates and was found to be
regulated by the envelope stress two-component regulatory
system BaeSR. An acrD mutant showed full virulence on
apple rootstock and immature pear fruits.
Methods
Bacterial strains, plasmids and growth conditions
Bacterial strains and plasmids used in this study are listed
in Table 4. E. amylovora strains were cultured at 28°C in
Lysogeny Broth (LB) or on LB plates. E. coli XL-1 Blue was
used as cloning host. E. coli cells were routinely maintained
at 37°C in LB or double Yeast Trypton (dYT) medium.
Cultures harboring individual vectors were supplemented
with 50 μg/ml ampicillin (Ap) for E. coli or 250 μg/ml for
E. amylovora, 25 μg/ml chloramphenicol (Cm), 2 μg/ml
gentamicin (Gm) and 25 μg/ml kanamycin (Km) when
necessary. Bacterial growth was monitored using a spec-
trophotometer at 600 nm (OD600).
PCR amplifications, modifications and protein purification
Primers (see Additional file 6) were designed based on E.
amylovora CFBP1430 genome sequences available from
NCBI (GenBank NC_013961.1). Screening PCR reactions
Table 4 Bacterial strains and plasmids used in this study
Plasmid or strain Relevant characteristics or genotypea Reference or source
Plasmid
pJET1.2 Apr, rep (pMB1) from pMBI responsible for replication Thermo scientific
pCAM-MCS Apr, pCAM140-derivative without mini-Tn5, contains the MCS of pBluescript II SK (+) [16]
pFCm1 Apr, Cmr, source of Cmr cassette flanked by FRT sequences [43]
pCAM-Km Kmr, variant of the gene replacement vector pCAM-MCS, Apr replaced by Kmr This study
pCAM-Km.acrD-Cm Kmr, Cmr, contains a 1.1-kb fragment of acrD from E. amylovora Ea1189, insertion of
1153-bp Cm-FRT cassette from pFCm1 in BamHI site
This study
pBlueScript II SK(+) Apr, ColE1 origin Stratagene
pBlueScript II KS(+) Apr, ColE1 origin Stratagene
pBBR1MCS Cmr, ColE1 origin [44]
pBlueKS.acrD Apr, contains a 3.1-kb fragment carrying acrD of E. amylovora Ea1189 under control
of lac promoter
This study
pBlueKS.acrD-ext Apr, contains a 3.5-kb fragment carrying acrD of E. amylovora Ea1189 including
promoter region under control of lac promoter
This study
pBlueSK.acrD Apr, contains a 3.1-kb fragment carrying acrD of E. amylovora Ea1189 in opposite
orientation with respect to lac promoter
This study
pBlueSK.acrD-ext Apr, contains a 3.5-kb fragment carrying acrD of E. amylovora Ea1189 including
promoter region in opposite orientation with respect to lac promoter
This study
pBBR.egfp.TIR Cmr, contains the TIR-egfp-T0 cassette in pBBR1MCS in opposite orientation with
respect to lac promoter
[16]
pBBR.acrD-Pro.egfp Cmr, contains a 206-bp fragment carrying the promoter region of acrD, transcriptional
fusion of acrD with egfp
This study
pBBR.acrA-Pro.egfp Cmr, contains a 133-bp fragment carrying the promoter region of acrA, transcriptional
fusion of acrA with egfp
This study
pBlueSK.baeR Apr, contains a 0.7-kb fragment carrying baeR of E. amylovora Ea1189 under control
of lac promoter
This study
pET-28a(+) Kmr, f1 origin Novagen
pET28a.baeR Kmr, contains a 0.7-kb fragment carrying baeR of E. amylovora Ea1189, C-terminal
translational fusion with His-tag
This study
pCP20 Cmr, Apr, contains yeast Flp recombinase gene, rep (pSC101) responsible for
temperature-sensitive replication
[45]
pBAD24 Apr, pMB1 origin, araC [46]










TG1 K-12 supE thi-1 Δ(lac-proAB) Δ(mcrB-hsdSM)5, (rK
-mK
- ) [47]
KAM3 acrAB mutant of TG1 [48]
BL21(DE3) F– ompT gal dcm lon hsdSB(rB
- mB
- ) (λDE3) Novagen
S17-1 TpR SmR recA, thi, pro, hsdR-M+RP4: 2-Tc:Mu: Km [49]
S17-1 λ-pir λpir phage lysogen of S17-1 [49]
DH5α λ-pir sup E44, ΔlacU169 (ΦlacZΔM15), recA1, endA1, hsdR17, thi-1, gyrA96, relA1, λpir
phage lysogen
D. Lies, Caltech
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Table 4 Bacterial strains and plasmids used in this study (Continued)
Erwinia amylovora
Ea1189 Wild type GSPBb
Ea1189-3 Kmr, acrB mutant carrying Kmr cassette in the acrB gene [16]
Ea1189.acrD acrD mutant This study
aApr, ampicillin resistance; Cmr, chloramphenicol resistance; Kmr, kanamycin resistance.
bGSPB, Göttinger Sammlung Phytopathogener Bakterien, Göttingen, Germany.
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(Thermo Scientific) in accordance with the manufac-
turer’s instructions and optimized annealing temperatures
based on the melting temperatures of the respective
primers. For high fidelity PCR reactions, Phusion DNA
polymerase (Thermo Scientific) was used where the
annealing temperature was 3°C higher than the lower
temperature of the used primer combination.
Restriction enzyme (Thermo Scientific) and T4 DNA
ligase (Thermo Scientific) reactions were performed as
per the manufacturer’s instructions at the appropriate
temperature where all ligation reactions were incubated at
room temperature.
DNA purifications were either performed using the
GeneJET PCR purification kit (Thermo Scientific) or the
GeneJET Gel extraction kit (Thermo Scientific) following
the manufacturer’s instructions.
Protein purification was carried out using the Ni-NTA
Spin Kit (Qiagen) following the manufacturer’s instructions.
Construction of the E. amylovora acrD-deficient mutant
A 1058-bp fragment located in the acrD gene was ampli-
fied using the primer pair acrD_ko_fwd and acrD_ko_rev
and verified by sequencing. A chloramphenicol cassette
flanked by Flp-FRT sites was cut from plasmid pFCM1
and inserted into BamHI-digested pJET.acrD-ko, yielding
pJET.acrD-ko.Cm. A 2.2-kb EcoRI fragment cut from
pJET.acrD-ko.Cm was ligated into EcoRI-digested pCAM-
Km, yielding the final replacement plasmid pCAM-Km.
acrD-Cm. The plasmid was transformed into electrocom-
petent cells of E. amylovora Ea1189, which subsequently
were grown for 3 h at 28°C in dYT broth. Putative mu-
tants were screened for homologous recombination events
by testing their antibiotic resistance. Mutants that resulted
from single crossover events were identified by their abil-
ity to grow on plates containing Km. In order to confirm
gene disruption through a double crossover event in Cm-
resistant and Km-sensitive colonies, primers acrD_fwd
and acrD_rev were designed, which bind upstream and
downstream, respectively, of the 1058-bp acrD fragment
used for generation of the gene replacement vector.
PCRs were done using these locus-specific primers with
primers binding in the Cm cassette (cat_out2, cat_out3,
cat_out4, cat_out5). Amplified PCR products were verified
by sequencing.The Cm-FRT cassette was finally excised using the
temperature-sensitive plasmid pCP20 that carries the
yeast Flp recombinase gene [43,45]. Briefly, Cm-resistant
mutants of Ea1189 were transformed with pCP20 and se-
lected at 28°C on LB plates containing Ap. Subsequently,
Ap-resistant transformants were streaked on non-selective
agar plates and incubated at 43°C for 1 h; following incu-
bation at 28°C for 48–60 h. Single colonies were selected
and tested on agar plates containing Cm or Ap to confirm
successful excision of the Cm cassette and loss of plasmid
pCP20.
Construction of acrD overexpression plasmids
A 3.06-kb fragment containing acrD was amplified from
E. amylovora Ea1189 using the primer pair acrD-ApaI
and acrD-SacI. The PCR product was sequenced and
further cloned into ApaI-SacI-digested pBlueScript II KS
(+) and pBlueScript II SK(+), respectively (pBlueKS.acrD,
pBlueSK.acrD).
Next, a 210-bp fragment containing the upstream region
of acrD was amplified using the primers narP-ApaI
and acrD_SalI. The PCR product was cloned into a SalI
restriction site located in the beginning of the acrD gene
(pBlueKS.acrD-ext, pBlueSK.acrD-ext).
Drug susceptibility tests
The minimal inhibitory concentrations (MIC) of drugs for
E. amylovora strains were determined by a 2-fold dilution
assay in Mueller-Hinton broth (MHB). All tests were done
in at least triplicate following the Clinical and Laboratory
Standards Institute recommendations [50]. Growth of bac-
teria at 28°C was examined by visual inspection after 48 h
incubation. The MIC was defined as the lowest concentra-
tion of an antibiotic that completely prevented visible cell
growth.
Generation of promoter-EGFP fusions
Transcriptional fusions between the promoter regions of
acrA and acrD, respectively, and egfp were created using
a previously described PCR-based method [51]. Briefly, a
546-bp fragment containing the upstream region of acrD
was amplified using the primer acrD_up and the reverse
primer acrD-P-egfp containing a 24-nt extension that
is homologous to the start of the egfp gene. The acrA
upstream region was amplified using the primer acrAB_fwd
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gene egfp was amplified using the primer pair egfp-ATG
and egfp-Cm and the plasmid pBBR.egfp.TIR [16] as the
template. All PCR products were gel-purified. For the
fusion reaction, 200 ng of a PCR fragment containing a
promoter region were mixed with 200 ng of the reporter
gene fragment. Nested primer pairs were used for the
fusion PCR reactions. For fusion of the acrD promoter
to the egfp gene, the primers acrD-P-fwd_SacII-2 and
uidA-t0-KpnI were used. The primers acrA-P-fwd-SacII
and uidA-t0-KpnI were used in a PCR to fuse the acrA
promoter to egfp. The PCR products were gel-purified to
remove non-fused fragments. Next, the fusion product
was cloned in opposite direction to the lacZ’ promoter,
into SacII-KpnI-treated pBBR1MCS, yielding plasmids
pBBR.acrA-Pro.egfp and pBBR.acrD-Pro.egfp.
Promoter activity of acrD in vitro
The reporter gene egfp was employed to study the impact
of diverse antimicrobial substances on promoter activities
of acrD in E. amylovora. Plasmids carrying the transcrip-
tional fusions were transformed into Ea1189. Antimicrobial
compounds were added to the bacterial cells in 96-well mi-
crotiter plates by the 2-fold dilution method as described
for MIC assays. EGFP fluorescence of the cells following
exposure to various concentrations of the substrates was
measured 48 hours after incubation at 28°C using the mi-
croplate reader Infinite M1000 PRO (Tecan, Crailsheim,
Germany) with an excitation wavelength of 470 nm and
emission detection at 516 nm.
Fluorescence values obtained were plotted versus optical
density in a scatter plot (see Additional file 5). A best-fit
linear regression line was added to the plot and a 95%
confidence interval determined. Data points that did not
meet the confidence interval criteria indicate fluorescence
values higher than the average, thereby suggesting induc-
tion of the acrD promoter by the respective compound.
To further demonstrate promoter induction, the iden-
tified substrates were tested in liquid cultures. Cells of
Ea1189 harboring plasmid pBBR.acrD-Pro.egfp were in-
cubated in LB broth supplemented with each substrate for
24 hours, then harvested by centrifugation, resuspended
in phosphate-buffered saline, adjusted to an OD600 value
of 0.1 and fluorescence determined.
Apple plant material and inoculation procedures
Apple plants (rootstock Malus MM106) were grown in a
greenhouse at 20 to 25°C, 60% humidity, and 12 h
photoperiod (15,000 lx). E. amylovora Ea1189 and its
acrD mutant, grown on LB agar for 24 h, were resus-
pended and diluted to a cell density of 1 x 106 CFU/ml in
sterile demineralized water. Apple plants were inoculated
by prick technique [52]. Each bacterial strain was inoc-
ulated into one shoot of five single plants. A bacterialsuspension (5 μl) was placed onto each wound on the shoot
tip. Plants were monitored for symptom development daily.
Survival of bacteria in plant tissue was examined by re-
isolation of bacterial cells 1 and 5 day(s) after inoculation,
respectively, from 1 cm of the shoot tip around the inocu-
lation area. Ultimately, five wounds were pooled together,
homogenized in 0.9% NaCl, serially diluted, and spread on
LB agar plates. The experiment was repeated in triplicate.
In order to analyze the abundance of acrA and acrD
mRNA transcripts in E. amylovora Ea1189 during growth
in apple rootstock MM106, total RNA was isolated from
infected apple shoots 1, 4 and 7 day(s) post inoculation,
respectively. Five individual wounds were pooled together,
homogenized in 0.9% NaCl and centrifuged for 2 min at
4000 rpm. The supernatant was transferred to 15 ml kill-
ing buffer (20 mM Tris–HCl, pH 7.5; 20 mM NaN3) [53]
and centrifuged for 20 min at 4000 rpm. The supernatant
was decanted and the pellet frozen at −80°C for further
RNA extraction.
Virulence assay on immature pears
Virulence of E. amylovora Ea1189 and its acrD mutant
was determined on immature pears (cv. ‘Bartlet’). Bacteria,
grown at 28°C on LB agar plates for 24 h, were resuspended
and adjusted to an OD600 of 1.0 in sterile demineralized
water for inoculation. Immature pear fruits were surface-
sterilized and pricked with a sterile needle as described pre-
viously [54]. Wounds were inoculated with 5 × 106 CFU/ml
and incubated in a humidified chamber at room tempe-
rature for 8 days. Disease symptoms were recorded by
means of diameter of necrosis surrounding the infection
site. Fruits were assayed in triplicates and the experiment
was repeated twice.
To analyze gene expression of E. amylovora Ea1189
during growth on pear fruits, immature fruits were cut
in slices (approx. 0.5 cm). Five slices were inoculated with
100 μl of a bacterial suspension adjusted to an OD600 of 1.0
in sterile demineralized water. The suspension was evenly
distributed on the slice and incubated for 12 hours in a hu-
midified chamber at room temperature. Next, the upper
layer of the surface was scratched from the five slices, re-
suspended in 25 ml of PBS and centrifuged for 2 min at
4000 rpm. The supernatant was transferred to 15 ml killing
buffer and further processed as described above.
RNA isolation and quantitative real-time PCR
Cell cultures were grown in LB broth until the desired
optical densities were achieved. An aliquot containing
15 × 109 CFU (equivalent of 15 ml OD600 of 1.0) was
transferred to 15 ml killing buffer and centrifuged for
20 min at 4000 rpm. The supernatant was decanted and
the pellet frozen at −80°C for further RNA extraction.
Total RNA was isolated by acid phenol/chloroform
extraction [53]. The obtained RNA was treated with
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and subsequently checked for purity by gel electrophoresis
and determination of the A260/A280 and A260/A230
ratios using a Nanodrop ND-2000 spectrophotometer
(Thermo Fischer Scientific). High quality RNA was reverse
transcribed and amplified with the OneStep RT-PCR Kit
according to the manufacturer’s protocol (Qiagen, Hilden,
Germany). Template RNA (5 ng) was used in a stand-
ard 25-μl qRT-PCR reaction with specific primers (see
Additional file 6). As negative control, RNA samples with-
out reverse transcriptase were included to detect possible
DNA contaminations.
For analysis, a Mastercycler ep realplex2 gradient S
(Eppendorf, Hamburg, Germany) was used. Cycling pa-
rameters included a 15 min initial denaturation at 95°C
to activate the DNA polymerase followed by 40 cycles
consisting of 15 sec at 95°C, 30 sec at 55°C and 30 sec at
72°C. The final step consisted of 1 min at 95°C and 30 sec
at 55°C. A melting curve analysis with a temperature ramp
from 25°C to 95°C in 20 min was performed at the end
of each run to determine specificity of amplified qPCR
products.
Each sample was analyzed for gene expression in tripli-
cate. Quantification of mRNA transcripts was performed
by the comparative Ct method. Briefly, the Ct values of the
samples of interest were compared with a non-treated sam-
ple. All Ct values were normalized to the housekeeping
gene recA, which shows constant expression at different
ODs and medium compositions as well as similar amplifi-
cation efficiency to the target genes [55]. The compara-
tive Ct method was calculated by 2−ΔCt ;sample−ΔCt ;reference ,
where ΔCt was normalized to the endogenous housekeeping
gene recA. Subsequently, fold-changes between the samples
were determined based on the calculated Ct method.Expression of the BaeR protein
Expression of BaeR was achieved by using the vector
pBAD24 where the expression is controlled by the PBAD
promoter and araC. Therefore, we cloned baeR under con-
trol of the arabinose inducible promoter (pBAD24.baeR)
and transformed the plasmid into E. amylovora wild-type
cells. Protein expression was induced by adding 1% L-ara-
binose when cultures reached an OD600 of 0.5. Cells were
further incubated for 1 hour at 28°C and subsequently
harvested by centrifugation.Electrophoretic mobility shift assay
DNA fragments used for the electrophoretic mobility
shift assay (EMSA) were PCR amplified using Cy5-labeled
primers to perform a non-radioactive EMSA. DNA frag-
ments used were the upstream region of acrD (246 bp),
and as controls, the upstream regions of acrAB (205 bp)
and tolC (291 bp). Approximately 0.16 pmol of Cy5-labeledDNA was mixed with increasing concentrations of His-
tagged BaeR protein in a binding buffer reaction (50 mM
Tris–HCl, pH 7.5; 1 mM DTT; 500 mM MgCl2; 100 mM
EDTA; 10 mM NaCl; 5% glycerol). To decrease unspe-
cific binding, 500 ng competitor DNA (Salmon sperm
DNA, AppliChem) was added to the reaction. Incubation
was done at room temperature for 30 min. The total reac-
tion was run on a native 4% polyacrylamide gel in 0.5x
Tris-borate-EDTA (TBE) buffer at constant 25 mA.
After electrophoresis, fluorescence signals of the labeled
DNA were visualized using a FLA-3000 phosphorimager
(Raytest, Straubenhardt, Germany).Statistical analysis
Statistical analysis was performed using R [56]. Differences
between two groups were determined by a two-sided t-test
with equal variances and were considered significant at
P < 0.05. When necessary the standard deviation is pre-
sented in the graph when the average of several values
was applied.Additional files
Additional file 1: Phylogenetic tree of AcrD. Description: The tree was
calculated based on AcrD from Erwinia amylovora Ea1189 (black arrow)
and its homologues from other members of the Enterobacteriaceae
family, including Erwinia pyrifoliae (95% identity), E. tasmaniensis (93%
identity), E. billingiae (83% identity), Pantoea agglomerans (82% identity),
P. ananatis (79% identity), Enterobacter cloacae (79% identity), Salmonella
enterica (79% identity), Citrobacter koseri (79%), Klebsiella pneumoniae
(79% identity), Escherichia coli (78% identity) and Shigella flexneri
(78% identity). The dendrogram was generated based on percentage of
identity between the sequences using the neighbor joining algorithm
implemented in Jalview [25-28].
Additional file 2: Sequence alignment of AcrD from Erwinia
amylovora Ea1189 and Escherichia coli K-12. Description: The
alignment is based on the amino acid sequences of AcrD using ClustalW
for analysis and Jalview for data presentation. AcrD of Ea1189 is 79%
identical and 89% similar to AcrD of E. coli K-12. Identical amino acid
residues are shown in blue. Yellow bars show a quantitative measurement
of conserved physico-chemical properties where the highest score
shows amino acids of the same physico-chemical class [26-28]. Black
bars indicate predicted transmembrane-spanning helices of AcrD from
E. amylovora [29].
Additional file 3: Modified view of the genomic organization of the
acrD locus. Description: The locus includes the region from Erwinia
amylovora CFBP1430, Escherichia coli K-12 and Salmonella enterica serovar
Typhimurium str. LT2, respectively, and was visualized by the Artemis
Comparison Tool [57]. The gray areas indicate homologous regions with
a minimum identity cutoff score of 88%. The region encoding acrD is
highlighted in light gray. The alignment was performed using the
nucleotide search BLASTN from NCBI.
Additional file 4: Membrane protein topology of AcrD from
Escherichia coli K-12 (A) and Erwinia amylovora Ea1189 (B).
Description: The upper line indicates the predicted topology from
TOPCONS [29] based on amino acid sequences. Red lines indicate an
inner membrane orientation; blue lines indicate an outer membrane
orientation. Grey boxes indicate transmembrane helices spanning from
the inside to the outside, white boxes indicate transmembrane helices
spanning from the outside to the inside. Below the line is a graphical
interpretation of the reliability of the prediction for each amino acid.
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http://www.biomedcentral.com/1471-2180/14/13Additional file 5: Scatter plot of the promoter activity of acrD from
E. amylovora Ea1189. Description: It shows the effect of substrates on
the promoter activity of acrD as determined by a transcriptional fusion
with the reporter gene egfp. Antimicrobial compounds were added to
cells of Ea1189 harboring pBBR.acrD-Pro.egfp by the 2-fold dilution
method as described for MIC assays. EGFP fluorescence of the cells
following exposure to various concentrations of the substrates was
determined after 24 h incubation. A best-fit linear regression line between
fluorescence and optical density values (dashed line) as well as a 95%
confidence interval (solid line) are indicated. Outliers (black spots), showing
higher fluorescence than the confidence interval, were identified as follows:
deoxycholate (Doc), naringenin (Ng), tetracycline (Tc), and zinc sulfate (Zn).
The following substrates were applied to this assay: (+)-catechin, acridine
orange, acriflavine, amikacin, azithromycin, benzalkonium chloride, berberine,
bile salts, cadmium acetate, chloramphenicol, ciprofloxacin, clarithromycin,
clotrimazol, cobalt chloride, copper sulfate, crystal violet, deoxycholate,
erythromycin, ethidium bromide, fusaric acid, fusidic acid, genistein,
gentamycin, josamycin, luteolin, myricetin, naladixic acid, naringenin, nickel
chloride, nitrofurantoin, norfloxacin, novobiocin, phloretin, polymyxin B,
quercitin, rhodamine 6G, rifampicin, roxithromycin, SDS, silver nitrate, sodium
arsenate, sodium tungstate, streptomycin, tetracycline, tetraphenylphospho-
nium chloride, tobramycin, and zinc sulfate.
Additional file 6: Primers used in this study.
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